Abstract:Purpose Parkinson’s disease (PD) is a neurodegenerative disease that usually leads to memory impairment, cognitive decline and dementia. Previous studies have reported that plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms play important roles in cardiovascular diseases, obesity, inflammation and other diseases. However, the role of PAI-1 in the diagnosis of Parkinson's disease has not been reported so far. Methods This study was a case–control study. This study included 131 PD patients and 97 healthy volunteers. polymerase chain reaction-restriction fragment length polymorphism (PCR–RFLP) was used to analyze the polymorphic loci of five different regions in PAI-1 gene (rs2227631, rs1799889, rs6092, rs2227694 and rs7242). 60 PD patients and 60 healthy volunteers were selected to detect the plasma PAI-1 concentration. The allele and genotype frequencies of SNPs were assessed using the SHEsis program. Results We found that GG genotype frequency and G allele frequency of rs2227631 was significantly higher in the PD patients. Statistically significant difference for rs1799889 could be observed in overdominant model. In subgroup analysis, a significant difference in genotype frequency distribution and allele frequency was found for rs2227631 and rs1799889 between early-onset PD group and the control group. For cognitive dysfunction, the subcomponent showed that GG genotype frequency and G allele frequency of rs2227631 was significantly higher in normal cognition group. The codominant model of rs1799889 was significantly different between the cognitive impairment group and the control group. In addition, the expression of PAI-1 in plasma of PD patients was significantly higher than that of controls, and further analysis showed that the expression of PAI-1 in patients with cognitive impairment was significantly higher than that in patients with cognitive normal. Conclusion Our results indicate that the PAI-1 gene rs2227631 and rs1799889 polymorphisms were significantly associated with PD susceptibility in the Chinese Han population. PAI-1 has the potential to become a new therapeutic target and diagnostic marker.

Genetic Associations of Plasminogen Activator Inhibitor-1-Related miRNA Variants with Coronary Artery Disease

Association Between Polymorphisms of Inflammatory Factor Genes and Coronary Heart Disease

Association of miR-146a rs2910164 and miR-499 rs3746444 polymorphisms with risk of ischemic stroke

The Association Between Pre-Mir-27a Rs895819 Polymorphism and Myocardial Infarction Risk in a Chinese Han Population

The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis

A Common Variant in Pre-Mir-146 is Associated with Coronary Artery Disease Risk and Its Mature Mirna Expression.

Association between HOTAIR lncRNA Polymorphisms and Coronary Artery Disease Susceptibility

Variations in Matrix Metalloproteinase-1, -3, and -9 Genes and the Risk of Acute Coronary Syndrome and Coronary Artery Disease in the Chinese Han Population.

Analysis of Plasma Mir-208A and Mir-370 Expression Levels for Early Diagnosis of Coronary Artery Disease

A 3' Untranslated Region Polymorphism of CTNNB1 (Rs2953) Alters MiR-3161 Binding and Affects the Risk of Ischemic Stroke and Coronary Artery Disease in Chinese Han Population

Association of MicroRNA Biogenesis Genes Polymorphisms with Risk of Large Artery Atherosclerosis Stroke

[Association Between Methylthioadenosine Phosphorylase Gene Single Nucleotide Polymorphisms and Myocardial Infarction in Chinese Han Ethnicity].

Association between MIF gene promoter rs755622 and susceptibility to coronary artery disease and inflammatory cytokines in the Chinese Han population

Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson’s disease in Chinese patients

Genetic association of five plasminogen activator inhibitor-1 (PAI-1) polymorphisms and idiopathic recurrent pregnancy loss in Korean women

PRISMA-combined Myeloperoxidase -463G/A Gene Polymorphism and Coronary Artery Disease

Variants Around miR-451 Can Affect the Risk of Large-artery Atherosclerosis Stroke in Chinese

Integrated microRNA–mRNA analysis of coronary artery disease

Single-nucleotide Polymorphism Rs731384 is Associated with Plasma Lipid Levels and the Risk of Coronary Artery Disease in Chinese Populations

Genetic Polymorphism of Matrix Metalloproteinase-1 and Coronary Artery Disease Susceptibility: a Case-Control Study in a Han Chinese Population.

Functional Variant in the SLC22A3-LPAL2-LPA Gene Cluster Contributes to the Severity of Coronary Artery Disease